Pine Valley Investments’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
WA
AFG
GIC
IHL
EAM
Pine Valley Investments's IBB Position: Q2 2026 in Review
Pine Valley Investments increased its iShares Biotechnology ETF (IBB) stake by 1% in Q2 2026, buying an estimated $6.88K and bringing the position to 3,992 shares worth $759K. The position accounts for 0.03% of the portfolio, ranked #340.
Pine Valley Investments first reported a position in IBB in Q1 2023 and has held it in 14 quarters since. The position peaked at $987K in Q3 2023. 550 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Pine Valley Investments held 3,992 shares of iShares Biotechnology ETF worth $759K as of Q2 2026.
- Pine Valley Investments bought 40 iShares Biotechnology ETF shares in Q2 2026, an estimated $6.88K.
- iShares Biotechnology ETF made up 0.03% of Pine Valley Investments's portfolio in Q2 2026, its #340 holding.
- Pine Valley Investments first reported a position in iShares Biotechnology ETF in Q1 2023 and has held it in 14 quarters since.
- Pine Valley Investments's iShares Biotechnology ETF position peaked at $987K in Q3 2023.
- 550 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Pine Valley Investments's 13F filing for Q2 2026, filed 24 Jul 2026.